Amneal Pharmaceuticals paid its 6 named executives $29.3M in total in FY2025 (Dec). CEO Chintu Patel was paid $8.7M of that.
Pay$100 in the stock at the end of FY20 → $760
Pay of each named executive
Chintu PatelCo-Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Chirag PatelCo-Chief Executive Officer and President
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Anastasios KonidarisEVP & Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Andrew BoyerEVP, Chief Commercial Officer - Generics
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Jason DalyEVP, Chief Legal Officer & Secretary
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Nikita ShahEVP, Chief Human Resources Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $9.0M. CEO pay of Amneal Pharmaceuticals for that year is not on file.
- 1Teva Pharmaceutical Industries
- 2United Therapeutics
- 3Supernus Pharmaceuticals
- 4Viatris
- 5PERRIGO Co
- 6Alkermes plc.
- 7Neurocrine Biosciences
- 8Prestige Consumer Healthcare
- 9Organon & Co.
- 10Amneal PharmaceuticalsThis companyNot disclosed
- 11Ani PharmaceuticalsNot disclosed
- 12Amphastar Pharmaceuticals, Inc.Not disclosed
- 13Emergent BioSolutions Inc.Not disclosed
- 14Jazz PharmaceuticalsNot disclosed
- 15Pacira BioSciences, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.